Auctus Investment Group Limited: FY23 Results

Aug 18, 2023

Auctus Investment Group Limited (ASX: AVC) a publicly traded private markets asset manager, has unveiled its robust financial outcomes for FY23. Noteworthy achievements include a remarkable 42% surge in Adjusted EBITDA, reaching AU$5.45 million, compared to FY22. The company's revenue showcased a commendable 40% escalation, totaling AU$16.41 million, with management fee revenue soaring by an impressive 56% to AU$6.24 million from the previous fiscal year. Auctus sustained an upward trajectory, boasting an 18% rise in annualized recurring revenue to AU$6.60 million.

Bolstered by prudent financial management, the firm maintains a strong balance sheet, boasting net assets of AU$28.76 million and a debt-free status. The FY23 Asset Management accomplishments highlight an 18% growth in Assets Under Management (AUM) to AU$533 million, marked by a 50% return on equity and 18% p.a. IRR from the successful sale of esVolta, LP. The sale of a stake in Petspiration Group (PETstock) is projected to further enhance Auctus's financial standing. These achievements are anticipated to lead to cash performance fees exceeding AU$9.68 million.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com